CD4 and neoplasm: In the investigated tumor areas, combination of PD-1 immune checkpoint blockade with Ad5/11-αCD3TAT-Trimer showed a significantly higher amount of total T cells including both total CD8+ and CD4+ T cells (Fig. EV5H).